Late Dr. La Montagne A 'Giant' In Infectious Disease
From Patricia Doyle, PhD
dr_p_doyle@hotmail.com
11-7-4
Hello, Jeff - Dr. La Montagne was an emerging infectious disease giant. During his career he worked on many diseases including SARS and HIV. He also has expertise in vaccine research.
Jeff, remember the list of emerging infectious disease experts really only contains the names of noted researchers. I wonder how many lesser-known infectious disease researchers have also died since 2001?
Patricia Doyle
http://alumni.hsc.tulane.edu/170th/montagne_profile.html
John R. La Montagne, PhD
Dr. John R. La Montagne, a native of Mexico City, Mexico, received his Ph.D. from Tulane University in 1971. In 1976, he came to the National Institutes of Health (NIH) as the Influenza Program Officer at the National Institute of Allergy and Infectious Diseases (NIAID). He became the Program Officer for the Viral Vaccines Program in 1983, and the Influenza and Viral Respiratory Diseases Program Officer in 1984. Beginning in 1986, Dr. La Montagne assumed the role of Director of the AIDS Program. In 1987 he was appointed Director of the Microbiology and Infectious Diseases Program, which became a Division in 1988. Dr. La Montagne was appointed Deputy Director of the NIAID in February 1998.
Dr. La Montagne has made significant contributions to the national and international effort against emerging and re-emerging infectious diseases, including biodefense activities, and is recognized internationally for his leadership in this area. He played a central role in the organization of the Multilateral Initiative on Malaria, an international effort involving research, control, and development agencies from the U.S., Europe, and Africa. In addition, he serves as a member of the Scientific Advisory Groups of Experts on Vaccines and Biologicals as well as for Vaccines and Immunization for the World Health Organization. He chaired the WHO Task Force on Strategic Planning for the Children,s Vaccine Initiative, advises the Pan American Health Organization on their programs in vaccine research implementation, and serves as a member of the board of the Global Alliance for Tuberculosis Drug Development. Dr. La Montagne also serves as a member of the Biomedical Research Confederation Executive Steering Committee at Ft. Detrick, Maryland, and as co-chair of the Research and Development Gaps Working Group, a component of the Weapons of Mass Destruction Subcommittee of the National
Science and Technology Council. His outstanding administrative leadership at NIH includes membership on the NIH Community Advisory Board for Security and the recently formed NIH Ethics Advisory Committee.
As an influential contributor to the field of infectious diseases, Dr. La Montagne has delivered numerous major lectures all over the world. He is the recipient of many prestigious awards for his scientific accomplishments, including the PHS Special Recognition Award for leadership in childhood vaccine research programs, the Surgeon General,s Certificate of Appreciation, the Presidential Meritorious Executive Rank Award, the Distinguished Executive Award for his work in the areas of infectious disease research of global health relevance, the Secretary,s Award for Distinguished Service for leadership of acellular pertussis vaccine trials, and most recently the Secretary,s Award for Distinguished Service for design and implementation of critically important biodefense strategies.
Patricia A. Doyle, PhD
Please visit my "Emerging Diseases" message board at:
http://www.clickitnews.com/ubbthreads/postlist.php?
Cat=&Board=emergingdiseases
Zhan le Devlesa tai sastimasa
Go with God and in Good Health